Apexigen
durable responses in sarcoma advanced soft tissue study of combination ongoing | Apexigen
Company
Deck Type
Sector
Industry
Deck date
March 2022
Slide
16 of 28
Related slides by other companies
ATAI
Investor Presentation
March 2023
may increase patient accessibility by reducing patient and clinic time commitment | ATAI
Ocuphire Pharma
Investor Day
January 2022
safety summary from phase and phase studies way | Ocuphire Pharma
ATAI
Investor Presentation
October 2022
may increase patient accessibility by reducing patient and clinic time commitment | ATAI
Ocuphire Pharma
Results
June 2021
patient population subject disposition | Ocuphire Pharma
Other recent decks by Apexigen
See all presentations (2 decks)
Investor Presentation
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights